H1B Salary Data

Home › Employers › PharmEng Technology

PharmEng Technology: H-1B salaries and sponsorship

PharmEng Technology filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $108,040.

Applications (LCAs)4
Certified4
Employer addressDurham, NC
H-1B dependent employerNo
Median offered salary$108,040
Middle half of salaries$97,695–$110,000
10th–90th percentile$82,601–$110,000

Does PharmEng Technology sponsor H-1B visas?

PharmEng Technology filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jan 9, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Specialist - Project Manager3$106,080
Project Manager1$110,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$110,000
FY20243$106,080

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Specialist - Project Manager$106,080
Level III
Algonquin, ILJan 9, 2024Jan 22, 2024Certified
Senior Specialist - Project Manager$110,000
Level III
Algonquin, ILDec 18, 2023Dec 20, 2023Certified
Senior Specialist - Project Manager$72,539
Level I
Algonquin, ILNov 13, 2023Nov 20, 2023Certified
Project Manager$110,000
Level IV
Kalamazoo, MIJul 24, 2023Aug 7, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).